HLA-open conformer-specific monoclonal antibody (ImmunOs Therapeutics)

N/A

Report date: 2025/03/20 15:14:38

Base Information

Drug NameHLA-open conformer-specific monoclonal antibody (ImmunOs Therapeutics)

Drug Alias NameOCi mAb

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionImmunomodulators

TargetsUpdating

Therapy Area/IndicationsPsoriasisInflammatory Bowel DiseasesSpondylarthritis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmunOs Therapeutics AG

China Registration ClassN/A

Develop Information

Active CompaniesImmunOs Therapeutics AG

Inactive CompaniesN/A

Active IndicationsPsoriasisInflammatory Bowel DiseasesSpondylarthritis

Inactive IndicationsN/A

Other Information

ATC CodeN/A